RELEASE DATE:  May 23, 2003

NOTICE:  NOT-CA-03-030

National Cancer Institute (NCI)

The Division of Cancer Control and Population Sciences (DCCPS) of the 
National Cancer Institute (NCI) announces a revision to NOT-CA-02-026 
for applications originally submitted under PAS-02-009, Cohort Studies 
in Cancer Epidemiology (NIH Guide October 11, 2001).  Revisions of 
applications originally submitted on either February 21, 2002, or 
February 21, 2003, may be submitted as revised applications for  
November 1, 2003.  NEW applications  may be submitted for  October 1, 
2003. These dates coincide with the standard receipt dates for NIH 
research grant applications.

The Division of Cancer Control and Population Sciences (DCCPS) of the 
National Cancer Institute (NCI) announced an annual receipt date for 
R01 applications from investigators intending to initiate, 
competitively supplement, or competitively renew epidemiologic cohort 
studies of human cancers.  It subsequently announced that revised 
applications only would be accepted on November 1, 2003.  This notice 
clarifies and revises the policy described in PAS-02-009, and published 
in the NIH Guide for Grants and Contracts on October 11, 2001.  This 
revised announcement  allows applicants to submit NEW applications on 
October 1, 2003, and REVISED applications on November 1, 2003.  In 
order to be considered as a REVISED application for PAS-02-009, the 
application must have already been reviewed under one of the previous 
receipt dates for PAS-02-009. An applicant planning to submit for  one 
of these additional receipt dates should adhere to the procedures and 
policies outlined in the original PAS and available at the following 
URL address:  https://grants.nih.gov/grants/guide/pa-files/PAS-02-009.html.  

Prospective applicants submitting new applications for the October 1, 
2003 receipt date are strongly encouraged to submit a Letter of Intent 
by September 1, 2003.  Prospective applicants submitting revised 
applications for the November 1, 2003, receipt date are strongly 
encouraged to submit a Letter of Intent by October 1, 2003.  A Letter 
of Intent should include the name, address, and telephone number of the 
Principal Investigator, the identities of other key personnel and 
participating institutions, and that the application is being submitted 
in response to PAS-02-009, Cohort Studies in Cancer Epidemiology.  
Although a Letter of Intent is not required, is not binding, and does 
not enter into the review of a subsequent application, the information 
that it contains allows NIH staff to estimate the potential review 
workload and plan for the application. 

The Letter of Intent, as well as requests for further information, 
should be sent to: 

Sandra L. Melnick, Dr.P.H.
Chief, Analytic Epidemiology Research Branch
Epidemiology and Genetics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
Executive Plaza North, Room 5100, MSC 7374
Bethesda, MD 20892-7324
Telephone:  (301) 435-4914
Fax:  (301) 402-4279
Email:  sm33k@nih.gov

Return to Volume Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.